Nov 022017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– ISRAEL, Ra'anana – UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced the appointment of Cynthia M.=> Read more

UroGen Pharma appoints Cindy Butitta to its Board of Directors

From:: UroGen Pharma appoints Cindy Butitta to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: